Emeis Stock Rises 2.7% to €14.81 Ahead of Q1 2026 Revenue Announcement
Emeis stock advanced 2.7% to €14.81 in mid-session trading on Tuesday, amidst a 0.62% rise in the CAC 40. The stock is nearing its resistance level of €15.06, just 24 hours before the Q1 2026 revenue release. Over the past year, the stock has gained 20.94%.
Stock Nears Resistance Ahead of Quarterly Earnings Release
The EMEIS stock is trading near the upper boundary of its Bollinger Bands, approximately 1% below the upper limit set at €14.93. The price has surpassed its 50-day moving average (€13.96) and its 200-day moving average (€13.61), indicating a bullish alignment that has supported the stock's rise since the end of April. The RSI at 57 remains neutral, showing no signs of exhaustion at this stage. The resistance threshold of €15.06 is within immediate reach, with the potential breach depending on the details of the upcoming announcement on Wednesday, May 6, when the group will disclose its Q1 2026 revenue.
Recovery Trajectory Confirmed by 2025 Financial Statements
The stock's rebound follows the annual earnings release. In the 2025 financial statements, the group, which specializes in retirement homes and clinics, reported a 19.2% increase in EBITDAR on a like-for-like basis and a two-point increase in occupancy rates, despite a net loss of €298 million. For 2026, the company expects EBITDAR growth to exceed 10%. Governance is also evolving. Jean-Marc Boursier will assume the role of Deputy CEO on July 1, while Olivier Dussopt has been proposed at the general meeting to succeed Guillaume Pepy as chairman of the board. The stock had also consolidated at the end of April following a TP Icap Midcap recommendation targeting €17. The next key event: the Q1 revenue, to be published on May 6.
